Tuberculosis (TB) is a serious bacterial infection that spreads through the air when an infected person coughs, sneezes, or speaks. The bacteria typically attack the lungs, but can spread to other parts of the body. Understanding TB testing matters because catching the infection early can prevent serious illness and stop transmission to others around you.
Learn About Paying Your FGUA Bill Online →
TB tests don't diagnose active TB disease by themselves—they detect whether TB bacteria are present in your body, either as an active infection or as a dormant (latent) infection. An estimated 1.7 billion people worldwide carry latent TB, meaning the bacteria are in their body but not causing illness and they cannot spread it to others. About 10% of people with latent TB will eventually develop active TB disease if untreated.
You might be offered a TB test in several common situations. Healthcare providers recommend testing if you've had close contact with someone who has active TB disease, if you have symptoms like a persistent cough lasting more than three weeks, fever, night sweats, or unexplained weight loss. You may also be tested as part of employment screening (particularly in healthcare, corrections, or childcare settings), when starting certain medications that weaken immunity, or if you're being evaluated for conditions like HIV that increase TB risk.
Two main types of TB tests exist: the tuberculin skin test (TST), also called the Mantoux test, and blood tests called interferon-gamma release assays (IGRAs). Both detect immune system responses to TB bacteria, but work slightly differently. Understanding which test you received and what happens next helps you interpret your results accurately.
Takeaway: TB testing identifies whether TB bacteria are present in your body, but positive results don't automatically mean you have active disease. Your healthcare provider will use additional information to determine what your specific results mean for your health.
The tuberculin skin test (TST) remains one of the most common TB screening methods worldwide. During the test, a healthcare provider injects a small amount of purified protein derivative (PPD) just under the skin, usually on your inner forearm. The injection itself is painless—you might feel a slight prick. The injection creates a small, pale bump that typically disappears within a few hours, and this is completely normal.
Free Guide to Pay by Plate Illinois Billing →
The critical part happens 48 to 72 hours after injection. During this waiting period, your immune system responds to the PPD. If your body has been exposed to TB bacteria, immune cells will travel to the injection site and cause swelling. You must return to your healthcare provider's office to have the test read at the correct time window. They measure the diameter of the hardened area (called induration) with a ruler, measuring only the raised, firm bump—not any surrounding redness.
TST results are reported in millimeters of induration. However, the interpretation depends on your personal risk factors. The CDC uses different cutoff measurements for different populations. For people with no known TB risk factors, an induration of 15 millimeters or larger is considered positive. For people with TB risk factors (such as close contact with TB, healthcare workers, or people with weakened immune systems), an induration of 10 millimeters or larger is positive. For people with HIV or severely weakened immune systems, 5 millimeters or larger is positive.
An induration smaller than these cutoffs is considered negative, meaning no immune response was detected. However, TST results can be false negatives if your immune system is very weak, if the test was performed incorrectly, or if testing happens too soon after TB infection (before the immune system has time to respond). Results can also appear negative in very young children and in late-stage HIV infection.
Takeaway: Your TST result is reported as millimeters of induration, but what that number means depends on your personal risk factors. A 12-millimeter result might be positive for one person and negative for another. This is why healthcare providers must review results in context of your individual situation.
Interferon-gamma release assays (IGRAs) are blood tests that measure how your immune system responds to TB antigens—specific TB proteins. The most commonly used IGRAs in the United States are QuantiFERON Gold In-Tube and T-SPOT.TB. These tests offer some advantages over the skin test: results come back in one to two days rather than requiring a return visit after 72 hours, they're not affected by previous BCG vaccination, and they may be more specific for TB infection.
Free Guide to Mold Removal Methods for Walls →
During an IGRA blood test, the laboratory mixes your blood sample with TB antigens and incubates it for 16 to 24 hours. During this time, if your immune system has encountered TB bacteria, specialized white blood cells (T-cells) produce interferon-gamma, a chemical messenger. The test measures how much interferon-gamma is produced. The lab compares your results to a control sample and provides a quantitative result—an actual measurement—plus an interpretation: positive, negative, or indeterminate.
A positive IGRA result means your immune system responded to TB antigens, indicating TB infection is present. However, like the TST, a positive IGRA does not distinguish between latent and active TB. A negative result suggests TB infection is not present, though false negatives can occur in people with very weak immune systems, early in infection, or in very young children.
The "indeterminate" category exists in IGRA testing when results fall in a gray zone. This can happen due to technical issues, improper sample handling, or an immune system that isn't mounting a clear response. An indeterminate result doesn't mean positive or negative—it means the test didn't provide a clear answer. Your healthcare provider may repeat the test or use a different method if you get an indeterminate result.
Some people receive conflicting results between TST and IGRA tests. For example, someone might test positive on a skin test but negative on a blood test, or vice versa. This occurs in about 5 to 10% of cases and reflects the different ways these tests measure immune response. When results conflict, healthcare providers consider your symptoms, exposure history, and other clinical factors to determine the most likely diagnosis.
Takeaway: IGRA blood tests provide results in days rather than requiring a return visit, but the interpretation logic is similar to the skin test—positive means TB infection is likely, negative suggests it's not, and indeterminate means the test was inconclusive.
A positive TB test result tells you that TB infection is present, but it's crucial to understand that this does not automatically mean you have active TB disease. This distinction matters significantly for your health management and for public health. A positive test is actually the beginning of the diagnostic process, not the end.
How to Delete Your Fitbit Account Guide →
If you have a positive TB test, your healthcare provider will ask detailed questions about your symptoms. Active TB disease typically causes a persistent cough lasting three weeks or longer, often with sputum (sometimes bloody), fever, chills, and night sweats. You may also experience chest pain when breathing or coughing and unexplained weight loss. These symptoms develop gradually and worsen over weeks. If you have these symptoms along with a positive TB test, active TB disease is more likely.
To distinguish between latent and active TB, healthcare providers use additional tests. A chest X-ray can show whether TB has caused lung damage or visible disease. Sputum smear tests and TB cultures can identify whether active TB bacteria are present and being shed. People with active TB produce sputum containing live bacteria and are contagious. People with latent TB have bacteria dormant in their body, show no symptoms, and cannot spread TB to others.
About 90% of people with latent TB infection never develop active disease in their lifetime. However, certain situations increase this risk substantially. People with HIV or other conditions causing severe immune suppression have roughly a 10% annual risk of developing active TB, compared to about 10% lifetime risk for those with normal immunity. Other risk factors that increase progression from latent to active TB include diabetes, kidney disease, cancer, immunosuppressant medications, malnutrition, substance abuse, and living in crowded congregate settings.
If latent TB is confirmed through testing and symptom evaluation, healthcare providers may recommend preventive therapy—medications taken for several months to kill dorm
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.